Home › Metabolic Disorders › NCT06546020
Gut Microbiota-dependent Health Impacts of Haskap Berries
PARTNERSHIP: Elucidating Gut Microbiota-dependent Health Impacts of Haskap Berries to Inform Agricultural Production Practices That Will Maximize Bioactive Potential
Who can join
Ages 35 to 65 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria for Metabolically Healthy Group: All of the following: * Waist circumference: men ≤ 40, women ≤ 35 inches * Systolic blood pressure: ≤ 130 mmHg * Diastolic blood pressure: ≤ 85 mmHg * Fasting glucose: ≤ 100 mg·dl-1 * Fasting triglycerides: ≤ 150 mg·dl-1 * HDL: men \> 40, women \> 50 mg·dl-1 Inclusion Criteria for Metabolically Unhealthy Group: Required: \- Waist circumference: men ≥ 40, women ≥ 35 inches AND ≥ 1 of the following: * Systolic blood pressure: \> 130 mmHg * Diastolic blood pressure: \> 85 mmHg * Fasting glucose: \> 100 mg·dl-1 * Fasting triglycerides: \> 150 mg·dl-1 * HDL: men ≤ 40, women ≤ 50 mg·dl-1 Exclusion Criteria: * BMI \<18 or \> 40 kg/m\^2 * potential allergy to Haskap or placebo ingredients * use of anti-inflammatory, lipid lowering, glucose lowering, blood pressure, or any other medications that may interfere with study measures * pregnant or lactating woman * diagnosis with type 1 or type 2 diabetes or any other condition that may interfere with study measures * smoke cigarettes * have taken antibiotics in the past 90 days * take supplements including pre/probiotics or "superfoods" within 30 days of starting the study * are planning on starting a weight loss or exercise regiment change * follow a specific diet such as low carbohydrate, vegan, and vegetarian * consume over 5 servings of fruit/vegetables per day * are unwilling to reduce caffeine intake to one 8 oz serving per day for the durations of the study
About the study
Polyphenol-rich Haskap berries (Haskap) have untapped therapeutic potential to improve human health, and agricultural producers in northern U.S. states are poised to increase production if consumer demand increases. A critical knowledge gap is that little is known about the interactions between gut microbes and Haskap polyphenols to produce bioactive metabolites linked to downstream health impacts. Additionally, little is known about which Haskap varieties and harvest timing yield the greatest bioactive potential. This study aims to address these gaps by investigating the interaction of bioactive components in Haskap with gut microbiota and the resultant gut and serum metabolites, inflammation, and metabolic health, and then couple this with analysis of berries from different Haskap varieties and harvest times.
What is being tested
- Haskap berry smoothie (dietary supplement)
- Placebo comparator (dietary supplement)
Sponsor: Montana State University · Participants: 120 · Started: Feb 26, 2025
Contact the study team
- Mary P Miles, PhD · Phone: 406-994-6678
- Zachary T Miller, PhD · Phone: (406) 961-3025
Official record on ClinicalTrials.gov — NCT06546020
Locations in the U.S.
| Montana | Montana State University, Bozeman |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.